Skip to main content
Premium Trial:

Request an Annual Quote

RareCyte Arv7/Synaptophysin Panel Kit

RareCyte's Arv7/Synaptophysin Panel Kit is a research-use-only dual-biomarker liquid biopsy assay for androgen receptor splice variant 7 (Arv7) and the neuroendocrine marker synaptophysin (SYP) that enables customers to evaluate the expression of both biomarkers on circulating tumor cells from prostate cancer patients. The assay comprises processing blood to slides with the AccuCyte Sample Preparation System followed by staining with the ARv7/Synaptophysin kit and imaging on a CyteFinder instrument. Machine learning-enabled analysis and scoring maximizes reviewer concordance. In addition, the RareCyte platform enables cell-free DNA analysis on the same sample, providing a comprehensive liquid biopsy assessment of tumor status, the company said.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.